digest
proteinas
inhibitor
aprotinin
clostripain
cystein
proteinas
yield
five
oligopeptid
fragment
two
fragment
exhibit
antivir
antibacteri
activ
two
fragment
antivir
activ
one
fragment
show
antimicrobi
activ
one
former
oligopeptid
show
antivir
activ
human
herp
simplex
viru
type
bovin
parainfluenza
viru
type
consist
hexapeptid
yfynak
correspond
amino
acid
intact
aprotinin
ident
synthet
pcptide
antivir
spectrum
natur
hexapeptid
exhibit
antibacteri
activ
also
devoid
trypsin
inhibit
activ
intact
aprotinin
contrast
ineffect
human
herp
simplex
viru
bovin
parainfluenza
viru
possess
antibacteri
properti
sever
bacteri
speci
j
appl
bact
aprotinin
also
known
bovin
pancreat
trypsin
inhibitor
one
studi
proteinas
inhibitor
isol
bovin
organ
tissu
aprotininlik
inhibitor
found
sever
organ
although
isol
extens
studi
sinc
precis
biolog
function
remain
unknown
one
properti
aprotinin
antimicrobi
activ
inhibit
growth
sever
gramposit
neg
bacteria
replic
influenza
virus
antibacteri
antivir
activ
attribut
proteinas
inhibitori
function
aprotinin
recent
report
bactericid
antiproteolyt
activ
aprotinin
relat
suggest
bactericid
potenc
aprotinin
due
instead
cation
hydrophob
properti
purpos
studi
determin
antimicrobi
action
aprotinin
requir
intact
molecular
conform
whether
discret
peptid
sequenc
within
molecul
fulfil
function
aprotinin
digest
proteinas
clostripain
yield
fragment
one
potent
antivir
activ
complet
character
synthet
produc
fragment
properti
discuss
report
correspond
author
fax
reagent
obtain
follow
sourc
aprotinin
contryk
gift
prof
oettel
veb
pharmazeutisch
kombinat
germ
dresden
germani
clostripain
methyl
cellulos
crystal
violet
cbromid
mtt
sigma
trypsin
porcin
pancrea
serva
fmocamino
acid
deriv
fmocli
tboc
resin
bachem
switzerland
prorpc
hr
hr
peprpc
hr
column
reversephas
chromatographi
pharmacia
bio
gel
fine
biorad
escherichia
coli
atcc
staphylococcu
aureu
atcc
roch
klebsiella
pneumonia
atcc
serratia
marcescen
atcc
staphylococcu
epiderm
atcc
eurodiagnost
shorehambi
sea
brighton
staphylococcu
lentu
bordetella
bronchiseptica
wildtyp
strain
institut
bacteriolog
veterinari
hospit
zfirich
bacillu
subtili
bga
merk
eagl
minimum
essenti
medium
lglutamin
amim
plate
nunc
madindarbi
bovin
kidney
cell
mdbk
pool
new
zealand
white
rabbit
kidney
cell
flow
laboratori
rhabdomyosarkom
cell
rd
human
herp
simplex
viru
type
gift
dr
wunderli
institut
immunolog
virolog
univers
ziirich
african
green
monkey
kidney
cell
vero
swine
testi
cell
st
equin
herp
viru
type
bovin
parainfluenza
viru
type
porcin
respiratori
corona
viru
prcv
institut
veterinari
virolog
ziirich
embryon
hors
lung
cell
ehl
prepar
institut
normal
abort
fetus
month
gestat
chemic
sequenc
analysi
purchas
appli
biosystem
inc
solvent
reagent
use
peptid
synthesi
purchas
fluka
singl
coloni
bacteria
grown
trypticas
soy
agar
plate
inocul
ml
trypticas
soy
broth
tsb
grown
overnight
ml
bacteri
suspens
dilut
tsb
bacteria
grown
logarithm
phase
organ
harvest
densiti
x
cfu
per
ml
cultur
centrifug
x
g
min
sediment
bacteria
wash
twice
mm
sodium
phosphat
buffer
ph
adjust
cfu
per
ml
bacteri
suspens
ad
test
solut
ul
tsb
mm
sodium
phosphat
buffer
ad
mixtur
incub
h
serial
tenfold
dilut
mm
sodium
phosphat
buffer
ph
plate
trypticas
soy
agar
plate
incub
h
distinct
coloni
could
count
assay
carri
duplic
antivir
activ
aprotinin
fragment
perform
follow
sampl
dissolv
eagl
minimum
essenti
medium
serum
free
contain
mm
hepe
antibiot
uml
penicillin
streptomycin
cell
grown
confluenc
plate
infect
tissu
cultur
infect
dose
viru
incub
min
c
nonadsorb
viru
discard
infect
cell
wash
phosphat
buffer
salin
pb
incub
tl
sampl
prepar
describ
cell
cultur
incub
clearli
detect
cytopath
effect
cpe
unprotect
infect
cell
visibl
h
uninfect
cell
incub
test
substanc
without
viru
evalu
cytotox
antivir
assay
perform
viru
homologu
system
human
rd
cell
line
equin
cell
line
ehl
bovin
cell
line
mdbk
prcv
porcin
cell
line
st
addit
test
heterolog
system
vero
cell
quantif
inhibit
perform
plaqu
reduct
assay
follow
plate
antivir
assay
frozen
thaw
three
time
supernat
serial
tenfold
dilut
eagl
minim
essenti
medium
inocul
appriopri
cell
monolay
grown
plate
vero
cell
ehvi
inocul
perform
supernat
min
cell
wash
overlaid
eagl
minim
essenti
medium
contain
fetal
calf
serum
wv
methyl
cellulos
incub
humid
atmospher
plaqu
visibl
h
methyl
cellulos
medium
remov
cultur
fix
methanol
final
stain
crystal
violet
plaqu
count
quantif
inhibit
perform
mtt
assay
modifi
follow
plate
antivir
assay
frozen
thaw
three
time
supernat
serial
tenfold
dilut
eagl
minim
essenti
medium
inocul
mdbk
cell
monolay
grown
plate
inocul
perform
supernat
min
ceil
wash
overlaid
ml
eagl
minim
essenti
medium
contain
fetal
calf
serum
incub
humid
atmospher
clear
damag
monolay
visibl
day
supernat
care
remov
substitut
ml
fresh
eagl
minim
essenti
medium
without
fetal
calf
serum
contain
mgml
mtt
incub
h
ml
acidifi
isopropanol
ml
concentr
per
ml
isopropanol
contain
vv
triton
ad
well
solubilis
cell
blue
cristal
min
invers
proport
extent
cell
destruct
read
inhibit
calcul
percent
reduct
cell
damag
yfynak
treat
infect
cultur
compar
untreat
infect
cultur
assay
antitrypt
activ
perform
nbenzoyllargininepnitroanilid
substrat
accord
method
geiger
fritz
peptid
concentr
determin
photometr
accord
gill
et
al
extinct
coeffici
cm
assum
sequenc
analysi
perform
model
gasphas
sequenc
appli
biosystem
inc
equip
onlin
pthamino
acid
analyz
model
appli
biosystem
inc
use
standard
chemic
program
synthesi
yfynak
perform
appli
biosystem
inc
model
peptid
synthes
hexapeptid
synthes
accord
fastmoc
strategi
use
l
hexafluorophosph
activ
agent
peptid
deprotect
cleav
resin
incub
mixtur
g
crystallin
phenol
ml
ethanedithiol
ml
thioanisol
ml
water
ml
trifluoroacet
acid
cleav
peptid
collect
precipit
tbutylmethyleth
centrifug
pellet
collect
wash
sever
time
tbutylmethyleth
aliquot
peptid
dissolv
vv
acet
acid
purifi
see
mg
aprotinin
dissolv
ml
trifluoroacet
acid
load
onto
prorpc
hr
column
equilibr
trifluoroacet
acid
column
elut
flow
rate
mlmin
fraction
ml
collect
collect
fraction
linear
gradient
vv
acetonitril
ml
vol
appli
aprotinin
elut
singl
peak
fraction
correspond
peak
pool
freezedri
clostripain
activ
follow
u
clostripain
dissolv
ul
mm
buffer
ph
contain
mm
mm
naci
mm
dtt
incub
h
room
temperatur
enzym
solut
store
use
longer
h
mg
purifi
aprotinin
dissolv
ml
tri
buffer
ph
ad
clostripain
solut
mixtur
incub
h
clear
centrifug
x
g
rain
clostripaindigest
aprotinin
ad
trifluoroacet
acid
final
concentr
vv
solut
ml
total
appli
prorpc
column
previous
equilibr
trifluoroacet
acid
acetonitril
vv
column
elut
flow
rate
mlmin
fraction
ml
collect
collect
fraction
linear
gradient
acetonitril
vv
appli
respect
peak
fraction
pool
freezedri
dri
sampl
dissolv
assay
antivir
activ
pool
ii
deriv
separ
aprotinin
fragment
acidifi
trifluoroacet
acid
final
concentr
vv
load
onto
prorpc
column
equilibr
trifluoroacet
acid
column
elut
flow
rate
mlmin
fraction
ml
collect
collect
four
fraction
linear
gradient
acetonitril
appli
peak
fraction
pool
freezedri
sequenc
aliquot
synthet
peptid
dissolv
vv
acet
acid
first
purifi
gelfiltr
biogel
column
x
cm
follow
reversephas
chromatographi
peprpc
hr
column
use
linear
gradient
acetonitril
ml
trifluoroacet
acid
digest
aprotinin
clostripain
period
h
result
appear
fragment
resolv
reversephas
chromatographi
fig
consist
five
peak
fraction
correspond
five
peak
pool
assay
antivir
activ
pool
contain
neither
antivir
antibacteri
activ
cytotox
cell
use
antivir
assay
pool
ii
iii
antivir
devoid
antibacteri
activ
pool
iv
v
contain
antivir
antibacteri
activ
pool
ii
rechromatograph
prorpc
hr
elut
diagram
step
consist
one
major
peak
fig
antivir
activ
toward
detect
oligopeptid
sequenc
found
yfynak
correspond
amino
acid
aprotinin
oligopeptid
artifici
synthes
purifi
sequenc
antivir
activ
confirm
character
assay
perform
synthet
oligopeptid
oligopeptid
inhibit
replic
rd
cell
dosedepend
manner
fig
effect
dose
pm
concentrauon
yfynak
reduc
replic
inhibitori
effect
observ
prcv
order
investig
whether
cell
type
import
inhibitori
effect
oligopeptid
antivir
assay
also
perform
vero
cell
concentr
oligopeptid
inhibit
replic
vero
cell
infect
amount
viru
use
rd
cell
vero
cell
sensit
compound
also
test
inhibitori
activ
use
less
viru
condit
oligopeptid
inhibit
replic
inhibit
replic
vero
cell
observ
aprotinin
assay
concentr
mm
effect
four
virus
test
compound
aprotinin
oligopeptid
cytotox
cell
use
assay
preincub
cell
oligopeptid
h
inocul
viru
result
antivir
effect
preincub
viru
peptid
h
inocul
cell
mixtur
also
ineffect
immedi
addit
viruspeptid
mixtur
cell
without
preincub
likewis
ineffect
antibacteri
activ
hexapeptid
determin
protein
concentr
use
antivir
assay
antibacteri
activ
detect
follow
gramposit
neg
bact
antitrypt
activ
oligopeptid
assay
concentr
mm
inhibit
trypsin
occur
although
intact
aprotinin
complet
inhibit
trypsin
equimolar
concentr
digest
aprotinin
clostripain
yield
five
oligopeptid
fragment
four
antivir
activ
although
nativ
molecul
exhibit
antivir
activ
clostripain
previous
use
fragment
human
cathepsin
g
basic
enzym
antibacteri
activ
relat
catalyt
properti
fragment
ii
complet
analys
sinc
difficulti
sequenc
peptid
synthesi
occur
pool
iii
iv
v
would
undu
delay
report
fragment
ii
fig
consist
hexapeptid
yfynak
correspond
amino
acid
aprotinin
sequenc
oligopeptid
inhibit
replic
ehl
vero
cell
prcv
inhibit
replic
rd
vero
cell
mdbk
cell
differenti
effect
indic
compound
may
interact
specif
virus
essenti
viral
replic
mechan
replic
inhibit
peptid
rd
vero
cell
multipl
infect
specif
cell
use
addit
replic
inhibit
either
ehl
vero
cell
differ
multipl
infect
thu
conclud
effect
yfynak
depend
cell
type
infect
peptid
devoid
antiproteinas
activ
intact
aprotinin
separ
activ
site
amino
acid
amino
acid
thu
relationship
antivir
activ
proteinas
inhibit
indic
intact
aprotinin
effect
four
virus
test
although
previous
demonstr
inhibit
influenza
viru
propag
chicken
embryo
observ
attribut
abil
aprotinin
block
proteolyt
activ
viru
spike
howev
control
experi
perform
use
inactiv
aprotinin
aprotinin
also
antibacteri
properti
probabl
unrel
antiproteinas
activ
new
antivir
activ
aprotininderiv
oligopeptid
detect
origin
compound
con
trast
situat
cystatin
inhibitor
cystein
proteinas
tripeptid
deriv
therefrom
short
oligopeptid
correspond
activ
site
inhibit
proteinas
also
inhibit
viral
multipl
parent
molecul
suggest
proteinas
inhibit
could
underli
mechan
system
cystatinand
aprotininderiv
peptid
may
similar
concern
site
chronolog
action
viru
replic
cycl
suggest
depend
observ
antivir
activ
order
addit
viru
vs
oligopeptid
case
prerequisit
antivir
activ
viru
appli
cell
h
respect
peptid
ad
sinc
preincub
virus
oligopeptid
affect
viral
infect
also
conclud
aprotininand
cystatinpeptid
function
defensin
ie
directli
neutral
virus
anoth
featur
common
cystatin
aprotinin
oligopeptid
requir
prolong
incub
h
viruscel
system
suppress
viral
activ
plu
fact
simultan
addit
viru
oligopeptid
cell
suppress
infect
indic
oligopeptid
compet
viru
receptor
site
cell
surfac
success
inhibit
viral
activ
occur
respect
oligopeptid
ad
viru
adsorpt
intern
continu
present
system
oligopeptid
function
inhibit
viral
replic
remain
unknown
possibl
virus
alter
cell
surfac
therebi
provid
new
bind
site
stimul
uptak
exogen
materi
cell
specul
yet
test
possibl
interact
mechan
